miR-21 |
Upregulated in AD |
N.D. |
33
|
miR-146a |
Upregulated in the skin and keratinocytes of AD
patients; alleviates chronic inflammation in a mouse model of AD |
IRAK1, CARD10, CCL5 |
34-36,38-40,164
|
miR-155 |
May influence the development of AD by downregulating
CTLA-4 in T cells and by modulation of the development of Th17 cells |
CTLA-4, SOCS1 |
37,42,76
|
miR-151a |
Altered in the blood plasma of AD patients, may
contribute to Th2 skewing and pathogenesis of AD |
IL12RB2 |
165
|
miRNA-143 |
May reduce the influence of IL-13 on epidermal
keratinocytes |
IL-13Rα1 |
166
|
miR-124 |
Suggested to decrease inflammation in chronic AD skin
lesions |
p65 |
167
|
miR-223 |
Upregulated in whole blood of AD patients |
N.D. |
143
|
miR-10a |
Upregulated in AD skin, inhibits keratinocyte
proliferation |
MAP3K7, HAS3 |
168
|